🟢 Intravenous Infusions is trading 7.27% up — catalyst remains unclear

Intravenous Infusions is trading at GHS 0.59, up 7.27%, with no clear company-specific explanation identified for the move.

• The company’s website lists an annual general meeting for October 23; the notice does not establish a cause.
• A supplied healthcare-sector rally offers positive context but does not confirm the reason for the Ghana-listed stock’s gain.
• Available reporting showed Ghana’s market was nearly flat on October 14; the catalyst for the October 15, 2026 move remains unclear.